IFUL Awarded Contract with National Cancer Institute
Insightful Corporation (NASDAQ: IFUL) said the National Cancer Institute has awarded Insightful two initial contracts worth approximately $185,807 to develop advanced bioinformatics software for analysis and evaluation of proteomic cellular signatures in cancer prevention research.
You May Also Be Interested In
- Dow Chemical (DOW) Wins $2.16B in K-Dow Arbitration
- Chinese official has said Chinese banks may fall short of the 2012 lending goal -Bloomberg
- HeartWare (HTWR) Publishes Encouraging Data from ADVANCE in Advanced Heart Failure
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
